Human trial starts on COVID-19 antibody trial therapy

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

A clinical trial is underway in China for an antibody treatment for COVID-19. 

The first health patient received experimental medication there on Monday. 

Eli Lilly says the US trial will begin within a few days. 

This is a phase 1 trial which means scientists are trying to find out if it is safe to used in humans. 

If proven safe, the next step will be to find out if it is effective against treating or preventing coronavirus. 

Antibody treatments are currently used to treat infections diseases and some forms of cancer. 

The Eli Lilly trial is being done in collaboration with a Chinese pharmaceutical company named Junshi Bioscience. 

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


get the app

My FOX8 News App

North Carolina Coronavirus Hotline: 1-866-462-3821

Follow FOX8 on Twitter